New data published from Canadian CCSVI prevalence study - National Multiple Sclerosis Society

Skip to navigation Skip to content

News

Share

New data published from Canadian CCSVI prevalence study

October 8, 2013

Results from a Canadian research study investigating the prevalence of CCSVI in MS and others was published early online on October 8, 2013 in the medical journal The Lancet. The team led by Dr. Anthony Traboulsee, University of British Columbia, with Dr. Katherine Knox, director of the Saskatoon MS clinic, was among seven teams supported by a joint initiative by the National MS Society and the MS Society of Canada.

Read details about this study on the MS Society of Canada’s Website.

About Multiple Sclerosis

Multiple sclerosis, an unpredictable, often disabling disease of the central nervous system, interrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million people worldwide.

Share